🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Pegozafermin reduced fibrosis at 24 weeks in NASH!

Impressive work describing novel biomarkers, including IL-6, uNGAL and copeptin. They can probably improve prognostication of patients with decompensated cirrhosis Ruben Hernaez #ajuanola #pgines #ma LiverUnit.Clinic.BCN Gut Journal LIVERHOPE gut.bmj.com/content/early/…

Thanks to AISF - Associazione Italiana Studio Fegato for this great opportunity! #TrainingDay #LiverTwitter

🤷Still very debated! 📚Check out our latest review! Albumin administration in internal medicine: A journey between effectiveness and futility 👏Enrico Pompili et al. link🖇️: ejinme.com/article/S0953-… Jacopo Imberti monica solbiati

Researching new therapies for decompensated #liver cirrhosis 💊💉 #DECISION4Liver

🟢🔴"Happy to share our latest #review just published in JCM MDPI #OpenAccess : "Role of #TIPS in management of #ascites in #liver #cirrhosis" #hepatology mdpi.com/2693998 Giacomo Zaccherini 🟡🔵

Thanks to AISF - Associazione Italiana Studio Fegato for the opportunity to present the results of the Real-ANSWER study on long-term #albumin treatment in decompensated #cirrhosis at the 56th Annual Meeting #livertwitter #hepatology doi.org/10.1016/j.dld.…

🆕Article in press❕ Prospective validation of the EASL management algorithm for acute kidney injury in cirrhosis 🔓#OpenAccess at👉journal-of-hepatology.eu/article/S0168-… #LiverTwitter

I was walking in Barcelona to my hospital and saw a fantastic young crow attending the EASL School on interpretation of liver biopsy for hepatologists. Thanks to Xavi Forns and Alba Diaz for organizing it !! #barcelonaeasl #livertwitter EASL Education EASLnews

Team #Bologna looking great! ✨ In DECISION, Università di Bologna leads WP5 & the #COMBATtrial, a clinical study to determine safety of a new combinatorial therapy for decompensated #cirrhosis 📸Enrico Pompili, Giacomo Zaccherini, Giulia Iannone, Greta Tedesco, Paolo Caraceni #EASLCongress

Thanks to @EASLnew!

Our #GeneralAssembly meeting has come to an end. We had a wonderful time in #Bologna, discussed our latest research results & leave with our heads full of new ideas for projects & collaboration! 💡 Save travels home everyone! #EUfunded #Horizon2020 Eur. Fdn. for the Study of Chronic Liver Failure European Liver Patients' Association Rautou Pierre-Emmanuel

Journalism is not a crime. Bring Cecilia Sala home. The journalist was arrested in Iran on December 19th and is now detained in Evin Prison. Tehran has chosen to challenge everything the West universally holds sacred: our freedom ilfoglio.it/esteri/2024/12…

❌💊 Simvastatin + rifaximin does not prevent ACLF development in decompensated cirrhosis ⏳10 years of work in the books 💪🏼 Salvatore Piano Giacomo Zaccherini Kohilan Gananandan Frank Uschner Jonel Trebicka Ruben Hernaez Juan G Abraldes Jordi Gratacós Ginès Koos de Wit EASLnews AASLD

many have been convinced to buy supplements recommended by influencers who promise better health But rarely they cause life threatening side effects. Like liver failure the influencers aren’t there to help when 💩 goes down.

📣Global Aki published in The Lancet Gastroenterology & Hepatology 🗺️3,821 patients with cirrhosis ✅38% had AKI ⚠️discrepancies in AKI management and outcomes ⚠️ AKI ➡️22.9% 28-day mortality 🎯Need for equitable & standardized care thelancet.com/journals/langa…

Wei-Yu Lu EASLnews Marta Alonso Peña, PhD Enrico Pompili Jesus Bañales Sven Francque Journal of Hepatology Enrico Pompili is presenting evidence that long-term albumin (LTA) is a safe, feasible outpatient treatment that can resolve ascites in over than half of patients, including some with refractory disease. 👉🏽Predictors of response to LTA can help personalised care! EASLnews

Thanks to EASL Education Marta Alonso Peña, PhD for the invitation and this great opportunity! #easl2025 #EASLCongress EASLnews Bologna Liver Science Study Group